Levocarnitine supplier Northeast Pharmaceutical fined by Chinese regulator for abuse of dominance
MLex Summary: Northeast Pharmaceutical Group has been fined 133 million yuan ($19.4 million) by the Liaoning provincial Administration for Market Regulation for abusing its dominance in the Chinese market for levocarnitine...To view the full article, register now.
Already a subscriber? Click here to view full article